Embark on a journey into the expertise of Dr. Ruchi Singh, where her seasoned and compassionate approach in the field of oncology sets the stage for personalized care and understanding. Dr. Ruchi Singh is a proud alumna of Gujarat University and B.J Medical College, Ahmedabad, where she earned her MBBS degree in September 2003 and completed her M.D. in Radiotherapy from Gujarat Cancer Research Institute (GCRI) in June 2013. As a proud member of the Association of Radiation Oncologists of India and the Oncology Forum, Dr.Ruchi Singh has dedicated her career to advancing the field and promoting the well-being of her patients.

Dr. Ruchi Singh's professional journey has been marked by a wealth of experience and a commitment to excellence in the field of oncology. Dr. Ruchi Singh's distinguished career in oncology spans key roles, starting as a Senior Resident at Safdarjung Hospital & VMMC, New Delhi (Oct 2013 - Mar 2014). She continued her impactful journey as a Senior Resident at Medanta- The Medicity, Gurgaon (Mar 2014 - Dec 2014), followed by Lok Nayak Hospital, MAMC, New Delhi (Dec 2014 - Jul 2017). Advancing in her profession, she served as an Associate Consultant at Max Hospital, Patparganj, New Delhi (Dec 2017 - Oct 2020). Presently, she holds the role of Consultant at IOSPL, Fortis Noida, reflecting her unwavering dedication to oncological excellence.

Dr. Ruchi Singh's academic prowess extends to impactful research, including a notable thesis on the "Comparative study of Weekly vs Three Weekly Cisplatin in Advanced Cases of Carcinoma Cervix along with Radiotherapy." Her dedication to advancing knowledge is further evident in her presentations, such as the award-winning "Analysis Of Levels Of Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-II In Patients Of Carcinoma Cervix" at the MP Gujarat Chapter Conference in 2011.

Moreover, Dr. Ruchi Singh's impactful contributions to oncology include diverse publications. In her paper on "Head and Neck Cancer Radiotherapy," she explores the transition from 2D to CyberKnife (Asian Journal of Radiation Oncology, 12/2013). She co-authored a chapter on "Carcinoma of Anal Canal" in "Principles and Management of Cancer" (January 2016) and contributed to "Radiotherapy for Paediatric Solid Tumours" (Paediatric Surgery Update, 2015). Her clinical studies, like "Extensive Re-ossification after Radiotherapy in Metastatic Carcinoma Breast" (Indian J SurgOncol, 2018) and "Desmoplastic Fibroma of Bone" (Indian J SurgOncol, 2018), showcase her expertise. In her latest work on "Aggressive Angiomyxoma" (Ann Clin Case Rep, 2021), Dr. Ruchi Singh continues to advance oncological knowledge, emphasizing her commitment to patient care.

Her commitment to professional development is showcased through active participation in conferences such as IFHNOS 2012 & 12 TH National Conference of FHNO, Ahmedabad, and the 1st Indian Cancer Congress & 35th AROI, 2013, New Delhi. Notably, her poster presentation on the "Comparative Study Of IMRT VS Conventional Radiotherapy With Amifostine For Preservation Of Parotid Function In Patients With Head And Neck Cancer" reflects her dedication to advancing treatment methodologies.

Dr. Ruchi Singh stands as a beacon of excellence, blending academic brilliance, extensive experience, and a genuine passion for improving the lives of those affected by cancer. Her holistic approach to patient care and continuous pursuit of knowledge make her a respected figure in oncology.